Financial results - MONOVIA PHARM SRL

Financial Summary - Monovia Pharm Srl
Unique identification code: 35269460
Registration number: J2015001941085
Nace: 7020
Sales - Ron
82.305
Net Profit - Ron
30.796
Employees
1
Open Account
Company Monovia Pharm Srl with Fiscal Code 35269460 recorded a turnover of 2024 of 82.305, with a net profit of 30.796 and having an average number of employees of 1. The company operates in the field of Activităţi de consultanţă în afaceri și management having the NACE code 7020.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Monovia Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 47.430 46.671 45.213 45.940 49.797 52.259 65.288 81.547 82.305
Total Income - EUR 0 47.430 47.400 45.213 45.940 50.317 52.259 72.046 81.768 82.349
Total Expenses - EUR 19 26.247 32.649 30.589 28.691 24.911 25.440 26.967 46.829 45.771
Gross Profit/Loss - EUR -19 21.184 14.751 14.625 17.249 25.405 26.819 45.079 34.938 36.578
Net Profit/Loss - EUR -19 17.487 12.176 14.173 16.326 24.080 25.602 43.388 30.102 30.796
Employees 0 2 2 2 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1.5%, from 81.547 euro in the year 2023, to 82.305 euro in 2024. The Net Profit increased by 862 euro, from 30.102 euro in 2023, to 30.796 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Monovia Pharm Srl

Rating financiar

Financial Rating -
MONOVIA PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Monovia Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Monovia Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Monovia Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Monovia Pharm Srl - CUI 35269460

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 134 0 15.638 11.513 7.527 5.951 3.687 3.234 33.238 28.762
Current Assets 45 22.812 3.761 5.422 10.618 19.821 24.351 43.282 21.850 31.060
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 0 4.364 3.634 3.868 3.793 4.734 4.629 32.049 19.978 28.555
Cash 45 18.448 127 1.554 6.825 15.087 19.722 11.232 1.872 2.506
Shareholders Funds 26 17.513 12.318 14.728 16.376 24.130 25.651 43.505 30.250 30.860
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 153 5.299 7.081 2.207 1.769 1.643 2.387 3.011 24.838 28.963
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7020 - 7020"
CAEN Financial Year 7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 31.060 euro in 2024 which includes Inventories of 0 euro, Receivables of 28.555 euro and cash availability of 2.506 euro.
The company's Equity was valued at 30.860 euro, while total Liabilities amounted to 28.963 euro. Equity increased by 779 euro, from 30.250 euro in 2023, to 30.860 in 2024.

Risk Reports Prices

Reviews - Monovia Pharm Srl

Comments - Monovia Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.